Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fishway is a biotechnology company and contract research organization (CRO) specializing in zebrafish-based models for drug discovery, safety evaluation, and efficacy testing. The company provides high-throughput screening services for the pharmaceutical, cosmetic, and nutraceutical industries, offering a rapid and cost-effective alternative to traditional mammalian testing. Their platform leverages the genetic and physiological similarities between zebrafish and humans to assess drug candidates across various therapeutic areas, including oncology, cardiology, and neurology. Fishway's services include acute toxicity testing, developmental toxicity, and organ-specific efficacy assays. The company is recognized as a pioneer in the industrialization of zebrafish technology for commercial R&D applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fishway.